Search

  • HOME
  • Search
Original Article
Tenofovir alafenamide treatment may not worsen the lipid profile of chronic hepatitis B patients: A propensity score-matched analysis
Joonho Jeong, Jung Woo Shin, Seok Won Jung, Eun Ji Park, Neung Hwa Park
Clin Mol Hepatol. 2022;28(2):254-264.   Published online December 28, 2021
View: 2422   Download: 223  Citations: 4
Editorial
Dyslipidemia in chronic hepatitis B patients on tenofovir alafenamide: Facts and puzzles
Hung-Yao Lin, Tai-Chung Tseng
Clin Mol Hepatol. 2022;28(2):181-182.   Published online February 21, 2022
View: 1739   Download: 85
Review
1621
Entecavir versus tenofovir in patients with chronic hepatitis B: Enemies or partners in the prevention of hepatocellular carcinoma
Sung Won Lee, Jonggi Choi, Seung Up Kim, Young-Suk Lim
Clin Mol Hepatol. 2021;27(3):402-412.   Published online June 23, 2021
View: 3669   Download: 212  Citations: 22
Original Article
Entecavir+tenofovir vs. lamivudine/telbivudine+adefovir in chronic hepatitis B patients with prior suboptimal response
Hyun Young Woo, Jun Yong Park, Si Hyun Bae, Chang Wook Kim, Jae Young Jang, Won Young Tak, Dong Joon Kim, In Hee Kim, Jeong Heo, Sang Hoon Ahn
Clin Mol Hepatol. 2020;26(3):352-363.   Published online May 28, 2020
View: 3292   Download: 164  Citations: 2
Review
1447
Unmet need in chronic hepatitis B management
Lilian Yan Liang, Grace Lai-Hung Wong
Clin Mol Hepatol. 2019;25(2):172-180.   Published online February 12, 2019
View: 7522   Download: 369  Citations: 41
Original Article
Efficacy of tenofovir-based rescue therapy for chronic hepatitis B patients with resistance to lamivudine and entecavir
Hee-Jeong Jeon, Seok Won Jung, Neung Hwa Park, Yujin Yang, Jin-Hee Noh, Jae-Sung Ahn, Hyung Rae Kim, Jae Ho Lee, Jung Woo Shin
Clin Mol Hepatol. 2017;23(3):230-238.   Published online June 30, 2017
View: 7906   Download: 159  Citations: 13
Editorial
Is tenofovir monotherapy a sufficient defense line against multi-drug resistant hepatitis B virus?
Yun Bin Lee, Jeong-Hoon Lee
Clin Mol Hepatol. 2017;23(3):219-221.   Published online September 19, 2017
View: 6616   Download: 147  Citations: 2
Original Article
Clinical impact of the early alanine amininotransferase flare during tenofovir monotherapy in treatment-naïve patients with chronic hepatitis B
Hee Yeon Seo, Han Ah Lee, Soon Young Ko, Joon Ho Wang, Jeong Han Kim, Won Hyeok Choe, So Young Kwon
Clin Mol Hepatol. 2017;23(2):154-159.   Published online May 8, 2017
View: 6308   Download: 169  Citations: 7
1334
Tenofovir has inferior efficacy in adefovir-experienced chronic hepatitis B patients compared to nucleos(t)ide-naïve patients
Goh Eun Chung, Eun Ju Cho, Jeong-Hoon Lee, Jeong-ju Yoo, Minjong Lee, Yuri Cho, Dong Hyeon Lee, Hwi Young Kim, Su Jong Yu, Yoon Jun Kim, Jung-Hwan Yoon, Fabien Zoulim
Clin Mol Hepatol. 2017;23(1):66-73.   Published online February 14, 2017
View: 8553   Download: 162  Citations: 11
1321
Efficacy of switching from adefovir to tenofovir in chronic hepatitis B patients who exhibit suboptimal responses to adefovir-based combination rescue therapy due to resistance to nucleoside analogues (SATIS study)
Hye Won Lee, Jun Yong Park, Beom Kyung Kim, Moon Young Kim, Jung Il Lee, Young Suk Kim, Ki Tae Yoon, Kwang-Hyub Han, Sang Hoon Ahn
Clin Mol Hepatol. 2016;22(4):443-449.   Published online November 25, 2016
View: 8377   Download: 154  Citations: 7
Case Report
Tenofovir-associated nephrotoxicity in patients with chronic hepatitis B: two cases
Hyeki Cho, Yuri Cho, Eun Ju Cho, Jeong-Hoon Lee, Su Jong Yu, Kook-Hwan Oh, Kyoungbun Lee, Syifa Mustika, Jung-Hwan Yoon, Yoon Jun Kim
Clin Mol Hepatol. 2016;22(2):286-291.   Published online June 25, 2016
View: 8576   Download: 164  Citations: 13
Original Article
The efficacy of tenofovir-based therapy in patients showing suboptimal response to entecavir-adefovir combination therapy
Jeong Han Kim, Sung Hyun Ahn, Soon Young Ko, Won Hyeok Choe, Kyun-Hwan Kim, So Young Kwon
Clin Mol Hepatol. 2016;22(2):241-249.   Published online June 15, 2016
View: 8605   Download: 131  Citations: 4
Editorial
Is the tenofovir based therapy almighty for previous treatment failure in chronic hepatitis B?
Hyung Joon Yim
Clin Mol Hepatol. 2016;22(2):238-240.   Published online June 25, 2016
View: 7117   Download: 91  Citation: 1
Original Article
1284
Comparison of tenofovir plus lamivudine versus tenofovir monotherapy in patients with lamivudine-resistant chronic hepatitis B
Chan Ho Park, Seok Won Jung, Jung Woo Shin, Mi Ae Bae, Yoon Im Lee, Yong Tae Park, Hwa Sik Chung, Neung Hwa Park
Clin Mol Hepatol. 2016;22(1):152-159.   Published online March 28, 2016
View: 8116   Download: 92
Tenofovir disoproxil fumarate monotherapy for nucleos(t)ide analogue-naïve and nucleos(t)ide analogue-experienced chronic hepatitis B patients
Sang Kyung Jung, Kyung-Ah Kim, So Young Ha, Hyun Kyo Lee, Young Doo Kim, Bu Hyun Lee, Woo Hyun Paik, Jong Wook Kim, Won Ki Bae, Nam-Hoon Kim, June Sung Lee, Yoon Jung Jwa
Clin Mol Hepatol. 2015;21(1):41-48.   Published online March 25, 2015
View: 6764   Download: 80  Citations: 10
Tenofovir disoproxil fumarate monotherapy for nucleos(t)ide-naïve chronic hepatitis B patients in Korea: data from the clinical practice setting in a single-center cohort
Sung Soo Ahn, Young Eun Chon, Beom Kyung Kim, Seung Up Kim, Do Young Kim, Sang Hoon Ahn, Kwang-Hyub Han, Jun Yong Park
Clin Mol Hepatol. 2014;20(3):261-266.   Published online September 25, 2014
View: 7773   Download: 70  Citations: 10
1 |

Clinical and
Molecular
Hepatology

Print ISSN: 2287-2728
Online ISSN: 2287-285X


Editorial Office
The Korean Association for the Study of the Liver
Room A1210, 53 Mapo-daero(MapoTrapalace, Dowha-dong), Mapo-gu, Seoul, 04158, Korea
TEL: +82-2-703-0051   FAX: +82-2-703-0071    E-mail: kasl@kams.or.kr
Copyright © The Korean Association for the Study of the Liver.         
COUNTER
TODAY : 916
TOTAL : 1128038
Close layer